Back to results

Massachusetts Institute of Technology

Development and application of mass spectrometry-based metabolomics methods for disease biomarker identification

Abstract

dc:description.abstract

Human societies face diverse health challenges including a rapidly aging population, rising incidence of metabolic disease, and increasing antibiotic resistance. These problems involve complex interactions between genes and environment and are often not well understood. To address these challenges, high-throughput and reproducible advances in genome sequencing, transcript measurement, and protein measurement have been developed; the information resulting from these techniques has led to an increased understanding of cellular function and the identification of number of novel biomarkers for a variety of diseases.In recent years, the monitoring of such systems-level cellular behavior has naturally extended to the metabolite level, leading to the study of metabolomics. The rise of metabolomics corresponds hand in hand with the desire to address some of the phenotypic informational gaps left behind from genomics, transcriptomics, and proteomics. The study of metabolites carries several advantages. First, the number of metabolites in the human "metabolome," estimated at 2500 metabolites, remains a tractable number for analysis as compared to the 35,000 genes and 100,000-1,000,000 proteins. Metabolites also reliably provide an instantaneous "downstream" biochemical snapshot of a cell, and the typical metabolomics analysis is carried out on relatively noninvasive patient fluids such as urine or plasma.The goal of this thesis is to design, develop, and apply methods for the metabolomic analysis of blood via gas chromatography-mass spectrometry (GC-MS) instrumentation. Despite initial successes, methods in metabolomics vary widely and have not been standardized. This was first addressed via the optimization of the instrumentation itself, a topic rarely addressed in the literature but crucial toward the reliable identification of biomarkers.

Degree

thesis:*
Department dc:contributor.department
Massachusetts Institute of Technology. Dept. of Chemical Engineering.
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2008

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Tong, Lily Victoria
Advisor dc:contributor.advisor
  • Gregory N. Stephanopoulos.

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/46014
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/46014

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Tong, Lily Victoria. Development and application of mass spectrometry-based metabolomics methods for disease biomarker identification. Massachusetts Institute of Technology, 2008. http://hdl.handle.net/1721.1/46014